We would like to highlight the following upcoming meetings
EACR 2026 Congress: Innovative Cancer Science
Organizer: The European Association for Cancer Research (EACR)
Date & Location: 08-11 June, 2026 | Budapest, Hungary
The 2026 Annual Congress of the European Association for Cancer Research (EACR 2025) is a four day congress dedicated to basic, preclinical and translational cancer research across a wide breadth of topics. It will highlight the latest research and bring together the cancer research community to inspire innovation and build knowledge, connections and collaborations.
Deadlines:
Abstract submission deadline: 04 March, 2026
EACR Travel Grant application deadline: 04 March, 2026
Early rate registration deadline: 21 April, 2026
Regular rate registration deadline: 18 May, 2026
12th Congress of the European Academy of Neurology (EAN) 2026
12th Congress of the European Academy of Neurology (EAN) 2026 – Geneva, Switzerland from 27–30 June 2026
Join us for the 12th EAN Congress in the vibrant city of Geneva! Under the overarching theme “Brains, Bytes & Beyond: Tech in Neurology”, the congress will explore how technological innovation and artificial intelligence are transforming the field of neurology - from restorative therapies to clinical reasoning and decision-making.
Set against the stunning backdrop of Lake Geneva and the Alps, this international meeting will bring together leading experts and professionals to share knowledge, discuss challenges, and shape the future of neurology.
Don’t miss this unique opportunity to connect, learn, and experience Geneva’s rich culture and breathtaking scenery.
To learn more about event: 12th Congress of the European Academy of Neurology - Geneva 2026 - ean.org
Brain Tumor Meeting 2026
Date & Location: October 14, 2026, 9:00am - October 15, 2026, 5:00pm | Berlin, Germany
More information: https://www.mdc-berlin.de/BTM2026
The 12th Brain Tumor Meeting will take place at the Max Delbrück Center in Berlin.
For 25 years, this meeting has brought together the international brain tumor community to discuss tumor biology, genetics, translational advances, and emerging therapeutic opportunities.
Why attend? The meeting is designed to foster interdisciplinary exchange and catalyze new collaborations across basic, translational, and clinical research. Who should attend? Scientists, clinicians, neuro-oncologists and technical staff at all career stages are all welcome.